Parathyroid hormone and calcitriol in hypertension caused by dietary calcium deficiency in rats

Journal of Vascular Research

Volumn 35, Issue 6, 1998, Pages 397-404

  López Miranda, Visitación ^a   Civantos, Beatriz ^a   Blasco, Rafael ^a   Hernández, Rosario ^a   De Artiñano, María Amaya Aleixandre ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Calcitriol; Dietary calcium deficiency; Hypertension; Parathyroid hormone

Indexed keywords

CALCITRIOL; CALCIUM; PARATHYROID HORMONE;

ANIMAL MODEL; ARTICLE; CALCIUM INTAKE; CONTROLLED STUDY; DIETARY INTAKE; EXPERIMENTAL MODEL; HYPERTENSION; MALE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; BLOOD PRESSURE; CALCITRIOL; CALCIUM; CALCIUM, DIETARY; HYPERTENSION; MALE; PARATHYROID GLANDS; PARATHYROID HORMONE; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY;

EID: 0032458188     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025610     Document Type: Article

References (101)

1. Grobbee DE, Waal-Manning HJ: The role of calcium supplementation in the treatment of hypertension: Current evidence. Drugs 1990; 39:7-18.
2. Aleixandre MA, Puerro M: Importancia del calcio en la dieta para la regulación de la presión arterial. Med Clin (Barc) 1993;101:660-667.
3. Aleixandre MA, Puerro M, Lizasoain I: Mecanismos alternativos del efecto hipotensor del calcio. Hipertensión 1993;10:96-102.
4. Hatton DC, McCarron DA: Dietary calcium and blood pressure in experimental models of hypertension: A review. Hypertension 1994; 23:513-530.
5. Pryer J, Cappuccio FP, Elliott P: Dietary calcium and blood pressure: A review of the observational studies. J Hum Hypertens 1995;9: 597-604.
6. Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P: Dietary calcium and blood pressure: A meta-analysis of randomized clinical trials. Ann Intern Med 1996;124:825-831.
7. Rambausek M, Ritz E, Rascher W, Kreusser W, Mann JF, Kreye VA, Mehls O: Vascular effects of parathyroid hormone (PTH). Adv Exp Med Biol 1982;151:619-632.
8. Stanton RC, Plant SB, McCarron DA: cAMP response of vascular smooth muscle cells to bovine parathyroid hormone. Am J Physiol 1984;247:E822-E826.
9. Crass MF 3rd, Moore PL, Strickland ML, Pang PKT, Citak MS: Cardiovascular responses to parathyroid hormone. Am J Physiol 1985;249: E187-E194.
10. Crass MF 3rd, Brewer KS: Vasorelaxant effect of parathyroid hormone on isolated segments of porcine coronary artery. Artery 1988;15:61-70.
11. Crass MF 3rd, Hulsey SM, Bulkley TJ: Use of a new pulsatile perfused rat aorta preparation to study the characteristics of the vasodilator effect of parathyroid hormone. J Pharmacol Exp Ther 1988;245:723-734.
12. Musso MJ, Barthelmebs M, Helwig JJ, Imbs JL: Renal vasodilator effect of parathormone. Arch Mal Cœur Vaiss 1989;82:1215-1218.
13. Di Pette DJ, Christenson W, Nickols MA, Nickols GA: Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology 1992;130:2045-2051.
14. McCarron DA, Pingree PA, Rubin RJ, Gancher SM, Molitch M, Krutzik S: Enhanced parathyroid function in essential hypertension: A homeostatic response to a urinary calcium leak. Hypertension 1980;2:162-168.
15. Strazzullo P, Nunziatya V, Cirillo M, Giannattasio R, Ferrara LA, Mattiolo PL, Mancini M: Abnormalities of calcium metabolism in essential hypertension. Clin Sci 1983;65:137-141.
16. Resnick LM, Muller FB, Laragh JH: Calcium-regulating hormones in essential hypertension: Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986;105:649-654.
17. Grobbee DE, Hackeng WHL, Birkenhager JC, Hofman A: Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J 1988; 296:814-816.
18. Young EW, McCarron DA, Morris CD: Calcium-regulating hormones in essential hypertension: Importance of gender. Am J Hypertens 1990;3(suppl):161-166.
19. Papagalanis ND, Skopelitis P, Kourti A, Kostogianni G, Karabatsos A, Genadious M, Thomas S, Samartzis M, Mountokalakis T: Urine calcium excretion, nephrogenous cyclic adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension. Nephron 1991;59:226-231.
20. Papagalanis N, Kourti A, Tolis A, Skopelitis P, Karabatsos A, Kostotanni G, Genadiov M, Elesaf M, Mountokalakis T: Effect of intravenous calcium infusion on indices of activity of the parathyroid glands and on urinary calcium and sodium excretion in normotensive and hypertensive subjects. Am J Hypertens 1993;6:59-65.
21. Van Hooft IM, Grobbee DE, Frolich M, Pols HA, Hofman A: Alterations in calcium metabolism in young people at risk for primary hypertension: The Dutch Hypertension and Offspring Study. Hypertension 1993;21:267-272.
22. St John A, Dick I, Hoak K, Retallack R, Welborn T, Prince R: Relationship between calciotropic hormones and blood pressure in elderly subjects. Eur J Endocrinol 1994;130:446-450.
23. Young EW, Morris CD, Holcomb S, McMillan G, McCarron DA: Regulation of parathyroid hormone and vitamin D in essential hypertension. Am J Hypertens 1995;8:957-964.
24. Christensson T, Hellström K, Wengle B: Hypercalcemia and primary hyperparathyroidism: Prevalence in patients receiving thiazides as detected in a health screen. Arch Intern Med 1977;137:1138-1142.
25. Zawada ET Jr, Brickman AS, Maxwell MH, Tuck M: Hypertension associated with hyperparathyroidism is not responsive to angiotensin blockade. J Clin Endocrinol Metab 1980; 50:912-915.
26. Vlachakis ND, Frederics R, Valasquez M, Alexander N, Singer F, Maronde RF: Sympathetic system function and vascular reactivity in hypercalcemic patients. Hypertension 1982;4: 452-458.
27. Ringe JD: Reversible hypertension in primary hyperparathyroidism: Pre- and postoperative blood pressure in 75 cases. Klin Wochenschr 1984;62:465-469.
28. Dominiczak AF, Lyall F, Morton JJ, Dargie HJ, Boyle IT, Tune TT, Murray G, Semple PF: Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci (Colch) 1990;78:127-132.
29. Lau K, Thomas D, Eby B: The nature and role of disturbances in calcium metabolism in genetic hypertension. Fed Proc 1986;45:2752-2757.
30. Bindels RJM, Van der Boek LAM, Jongen MJM, Hackeng WHL, Lowik CWGM, Van Os CH: Increased plasma calcitonin levels in young spontaneously hypertensive rats: Role in disturbed phosphate homeostasis. Pflügers Archs 1987;408:395-400.
31. Merke J, Lucas PA, Szabo A, Cournot-Witmer G, Mall G, Bouillon R, Drüeke J, Mann J, Ritz E: Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. Hypertension 1989;13:233-242.
32. Brickman AS, Nyby MD, Von Hungen K, Eggena P, Tuck M: Calciotropic hormones, platelet calcium, and blood pressure in essential hypertension. Hypertension 1990;16:515-522.
33. Shingu T, Matsuura H, Kusaka M, Inoue I, Yuasa A, Shingu T, Ishida T, Kajiyama G: Significance of intracellular free calcium and magnesium and calcium-regulating hormones with sodium chloride loading in patients with essential hypertension. J Hypertens 1991;9:1021-1028.
34. Oshima T, Tsubokura T, Matsuura H, Kainouchi M, Kajiyama G, McCarron DA: Lack of effect of parathyroid hormone on calcium homeostasis in rat platelets. Am J Hypertens 1992;5:823-826.
35. Kishimoto H, Tsumura K, Fujioka S, Uchimoto S, Morii H: Chronic parathyroid hormone administration reverses the antihypertensive effect of calcium loading in young spontaneously hypertensive rats. Am J Hypertens 1993;6:234-240.
36. Hatton DC, Yue Q, McCarron DA: Mechanisms of calcium's effects on blood pressure. Semin Nephrol 1995;15:593-602.
37. Nyby MD, Hino T, Berger ME, Ormsby BL, Golub MS, Brickman AS: Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein. Endocrinology 1995;136:2497-2504.
38. Oshima T, Young EW: Systemic and cellular calcium metabolism and hypertension. Semin Nephrol 1995;15:496-503.
39. Pang PK, Wang R, Shan J, Karpinski E, Benishin CG: Specific inhibition of long-lasting, L-type calcium channels by synthetic parathyroid hormone. Proc Natl Acad Sci USA 1990;87: 623-627.
40. Wang R, Karpinski E, Pang PK: Parathyroid hormone selectively inhibits L-type calcium channels in single vascular smooth muscle cells of the rat. J Physiol (Lond) 1991;441:325-346.
41. Bukoski RD, Ishibashi K, Bian K: Vascular actions of the calcium-regulating hormones. Semin Nephrol 1995;15:536-549.
42. Schlüter KD, Piper HM: Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998;37:34-41.
43. Schiffl H, Sitter T, Lang SM: Noradrenergic blood pressure dysregulation and cytosolic calcium in primary hyperparathyroidism. Kidney Blood Press Res 1997;20:290-296.
44. Bogin E, Massry SG, Harary I: Effect of parathyroid hormone on rat heart cells. J Clin Invest 1981;67:1215-1227.
45. Reid IR, Civitelli R, Halstead LR, Avioli LV, Hruska KA: Parathyroid hormone acutely elevates intracellular calcium in osteoblast-like cells. Am J Physiol 1987;253:E45-E51.
46. 2+ in rat proximal tubules. Am J Physiol 1990;258:F545-F552.
47. Chausmer AB, Sherman BS, Wallach S: The effect of parathyroid hormone on hepatic cell transport of calcium. Endocrinology 1972;90: 663-672.
48. Kawashima H: Parathyroid hormone causes a transient rise in intracellular ionized calcium in vascular smooth muscle cells. Biochem Biophys Res Commun 1990;166:709-714.
49. Gairard A, Berthelot A, Schleiffer R, Pernot F: Parathyroidectomy significantly decreases hypertension in spontaneously hypertensive and deoxycorticosterone plus saline treated rats. Can J Physiol Pharmacol 1982;60:208-212.
50. Mann JFE, Wiecek A, Bommer J, Ganten V, Ritz E: Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. Nephron 1987;45:46-52.
51. Pang PKT, Lewanczuk RZ: Parathyroid origin of a new circulating hypertensive factor in spontaneously hypertensive rats. Am J Hypertens 1989;2:898-902.
52. Lau K, Gafter U, Rydell D, Eby B, Pesigan M, Tropp I, Garno J, Zikos D: Evidence against the role of calcium deficiency in genetic hypertension. Hypertension 1986;8:45-49.
53. Togari A, Arai M, Shamoto T, Matsumoto S, Nagatsu T: Elevation of blood pressure in young rats fed a low calcium diet. Biochem Pharmacol 1989;889-893.
54. Shamoto T: Pharmacological study on blood pressure in rats with bone disorders. Aichi Gakuin Daigaku Shigakkai Shi 1989;27:989-1005.
55. Lewanczuk RZ, Wang J, Zhang ZR, Pang PK: Effects of spontaneously hypertensive rat plasma on blood pressure and tail artery calcium uptake in normotensive rats. Am J Hypertens 1989;2:26-31.
56. Benishin CG, Lewanczuk RZ, Pang PK: Purification of parathyroid hypertensive factor from plasma of spontaneously hypertensive rats. Proc Natl Acad Sci USA 1991;88:6372-6376.
57. Lewanczuk RZ, Pang PK: Parathyroid hypertensive factor is present in DOCA-salt but not in two-kidney-one-clip hypertensive rats. Am J Hypertens 1991;4:802-805.
58. Pank PK, Benishin CG, Lewanczuk RZ: Parathyroid hypertensive factor, a circulating factor in animal and human hypertension. Am J Hypertens 1991;4:472-477.
59. Pang PK, Lewanczuk RZ, Benishin CG: Parathyroid glands and cardiovascular functions; in Morii H (ed): Calcium-Regulating Hormones. Contrib Nephrol. Basel, Karger, 1991, vol 90, pp 65-71.
60. Schluter H, Quante C, Buchholz B, Dietl KH, Spieker C, Karas M, Zidek W: A vasopressor factor partially purified from human parathyroid glands. Biochem Biophys Res Commun 1992;188:323-329.
61. Lin CM, Saito K, Tsujino T, Yokoyama M: Calcium supplementation inhibits the expression of parathyroid hypertensive factor in DOCA-salt-hypertensive rat. Am J Hypertens 1994;7:201-204.
62. Pernot F, Burkhard C, Gairard A: Parathyroid cross-transplantation and development of high blood pressure in rats. J Cardiovasc Pharmacol 1994;23(suppl 2):18-22.
63. Barlet JP, Coxam V, Davicco MJ: Relation between the parathyroid glands and arterial pressure: Is there a parathyroid hypertensive factor? Presse Méd 1995;24:1703-1706.
64. 3 binds specifically to rat vascular smooth muscle cells and stimulates their proliferation in vitro. Life Sci 1988;42: 215-223.
65. 3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991;87:1889-1895.
66. 45Ca uptake by primary cultures of aortic myocytes of spontaneously hypertensive and Wistar Kyoto normotensive rats. Biochem Biophys Res Commun 1987;146:1330-1335.
67. 3 enhances resistance artery contractile properties. Hypertension 1990;16:523-531.
68. 45Ca uptake in vascular myocytes cultured from spontaneously hypertensive and normotensive rats. Life Sci 1991;49:651-659.
69. 3. Am J Hypertens 1993;6:388-396.
70. 3 induced alterations in vascular reactivity in the sponatneously hypertensive rat. Am J Med Sci 1994;307(suppl): 154-158.
71. Simosawa T, Ando K, Fujita T: Enhancement of vasoconstrictor response by a noncalcemic analogue of vitamin D. Hypertension 1993;21: 253-258.
72. Okamoto K, Aoki K: Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963;27:282-293.
73. Wright GL, Rankin GO: Concentrations of ionic and total calcium in plasma of four models of hypertension. Am J Physiol 1982;243: H365-H370.
74. American Institute for Nutrition Ad hoc Committee on Animal Nutrition: 1976 Report on Animal Nutrition. J Nutr 1977;107:1340-1348.
75. Buñag RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 1973;34:79.
76. Poole TB: The laboratory rat; in Poole TB (ed): Handbook on the Care and Management of Laboratory Animals, ed 6. UFAW. England, Longman Scientific & Technical, 1987, vol 19, pp 309-331.
77. Weissman N, Pileggi V: Iones inorgánicos; in Henry RJ, Cannon DC, Winkelman JW (eds): Química Clínica: Principios y Técnicas, ed 2. Barcelona, JIMS, 1980, vol 19, pp 643-762.
78. Calvo MS, Gundberg CM, Heath H III, Fox J: Homologous amino-terminal radioimmunoassay for rat parathyroid hormone. Am J Physiol 1991;261:E262-E268.
79. Hollis BW: 1,25-Dihydroxyvitamin D by RIA after immunoextraction. Clin Chem 1995;41: 1313-1314.
80. McCarron DA, Yung NN, Ugoretz BA, Krutzik S: Disturbances of calcium metabolism in the spontaneously hypertensive rat: Attenuation of hypertension by calcium supplementation. Hpyertension 1981;4:1162-1167.
81. Stern N, Lee DBN, Sillis V, Beck FWJ, Deftos S, Manolagas C, Sowers JR: Effects of a high calcium intake on blood pressure and calcium metabolism in young SHR. Hypertension 1984;6:639-646.
82. Barbagallo M, Resnick LM, Sosa E, Corbett ML, Laragh JH: Renal divalent cation excretion in secondary hypertension. Clin Sci 1992; 83:561-565.
83. McCarron DA: Low serum concentrations of ionized calcium in patients with essential hypertension. N Engl J Med 1982;307:226-228.
84. Resnick LM, Laragh JH, Sealey JE, Alderman MH: Divalent cations in essential hypertension: Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med 1983;309:888-891.
85. Lind L, Lithell H, Gustafsson IB, Pollare T, Ljunghall S: Calcium metabolism and sodium sensitivity in hypertensive subjects. J Hum Hypertens 1993;7:53-57.
86. Blaustein MP: Sodium ions, calcium ions, blood pressure regulation, and hypertension: A reassessment and a hypothesis. Am J Physiol 1977;232:C165-C173.
87. Thomson LE, Rinaldi GJ, Bohr DF: Decreased activity of the sodium-calcium exchanger in tail artery of stroke-prone spontaneously hypertensive rats. Blood Vessels 1990;27:197-201.
88. Ashida T, Kawano Y, Yoshimi H, Kuramochi M, Omate T: Effects of dietary salt on sodium-calcium exchange and ATP-driven calcium pump in arterial smooth muscle of Dahl rats. J Hypertens 1992;10:1335-1341.
89. + and cell membrane adenosine triphosphatase activity in essential hypertension in blacks. J Hypertens 1992;10:571-578.
90. 2+-ATPase activity in essential and renal hypertension. Clin Exp Hypertens 1993;15:143-152.
91. 2+ ATPase in erythrocytes from subjects with essential hypertension and Raynaud's phenomenon. Am J Hypertens 1994;7:90-95.
92. +-ATPase inhibition on cytosolic free calcium ions in vascular smooth muscle cells of spontaneously hypertensive and normotensive rats. J Hypertens 1994;12:1007-1012.
93. +. J Clin Invest 1985;76:1147-1154.
94. 2+ metabolism using the saturation kinetics model. Am J Physiol 1987;253:R501-R508.
95. Geiger H, Bahner U, Palkovits M, Seewaldt B, Heidland A: Is the effect of calcium diet or parathyroidectomy on the development of hypertension in spontaneously hypertensive rats mediated by atrial natriuretic peptide? Kidney Int 1988;34(suppl 25):93-97.
96. Mulvany MJ, Korsgaard N, Nyborg N: Evidence that the increase of calcium sensitivity of resistance vessels in SHR is an intrinsic defect of their vascular smooth muscle cells. Clin Exp Hypertens 1981;3:749-761.
97. Shan J, Resnick LM, Lewanczuk RZ, Karpinski E, Li B, Pang PK: 1,25-Dihydroxyvitamin D as cardiovascular hormone: Effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am J Hypertens 1993;6: 983-988.
98. 3 blunts parathyroid hormone induction of kidney 1-hydroxylase. Arch Biochem Biophys 1995; 319:535-539.
99. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 1995;136:1419-1425.
100. López-Miranda V, Ortega A, Puerro M, Aleixandre A: Arterial blood pressure and growth patterns in spontaneously hypertensive rats fed on calcium-deficient diets. Pharmacol Rev Commun 1996;8:291-297.
101. Young EW, Bukoski RD, McCarron DA: Calcium metabolism in essential hypertension. Proc Soc Exp Biol Med 1988;187:123-141.